María Isabel
Morosini
María Isabel Morosini-rekin lankidetzan egindako argitalpenak (5)
2003
-
Erratum: Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation (Antimicrobial Agents and Chemotherapy (2003) 47:4 (1464-1467))
Antimicrobial Agents and Chemotherapy
-
Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation
Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 4, pp. 1464-1467
-
Haemophilus influenzae blaROB-1 mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefotaxime and β-lactamase inhibitors and increased susceptibility to cefaclor
Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 8, pp. 2551-2557
2002
-
Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 2, pp. 528-530
1998
-
An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection
FEMS Microbiology Letters, Vol. 165, Núm. 1, pp. 85-90